A First-in-human Clinical Trial Using a Gene Therapy With Patient's Own Stem Cells to Treat Early Type 1 Diabetes

Clinical trial NCT06938334 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06938334
Sponsor: Altheia Science
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diabetes, Type I

Start date: 2025-08-15
Primary completion: 2029-06-15
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.